Anamnesis, Pathological Assessment, Therapeutic Features and Course of Disease: Retrospective Study on Clinical-Based Factors for Prediction of Cancer-Specific Survival of 378 Patients with Stage pT1 Urothelial Bladder Carcinoma
Aktuelle Urol. 2015;46(3): 221-6 Breyer J, Otto W, Hartmann A, Bumes B, Bründl J, Gierth M, Bertz S, Denzinger S, Burger M, Lausenmeyer EM
Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer
Aktuelle Urol. 2015;46(3): 236-41 Mayr R, Pycha A
Asymptomatic kidney stones: active surveillance vs. treatment
Aktuelle Urol. 2015;46(5): 391-4 Neisius A, Thomas C, Roos FC, Hampel C, Fritsche HM, Bach T, Thüroff JW, Knoll T
Percutaneous Stone Treatment Today: Standard-, Mini-, Micro-, Ultramini-PCNL
Aktuelle Urol. 2015;46(4): 297-302 Wilhelm K, Fritsche HM, Netsch C, Für die AG ,,Endourologie und Urolithiasis" der GeSRU Academics
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma
Ann Oncol. 2015;26(8): 1754-9 Gakis G, Morgan TM, Daneshmand S, Keegan KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Efstathiou JA
Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
Ann Surg Oncol. 2015;22(3): 1032-42 Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Gierth M, Pahernik SH, Protzel C, Roigas J, Gördük M, Lusuardi L, May M, Trinh QD, Fisch M, Chun FK, PROMETRICS 2011 Research Group
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients
BJU Int. 2015;115(5): 722-7, Lucca I, Rouprêt M, Kluth L, Rink M, Tilki D, Fajkovic H, Kassouf W, Hofbauer SL, de Martino M, Karakiewicz PI, Briganti A, Trinh QD, Seitz C, Fritsche HM, Burger M, Lotan Y, Kramer G, Shariat SF, Klatte T
Reply to progression-free survival: does a correlation with survival left its role as a surrogate clinical endpoint?
Cancer. 2015;121(11): 1906-7 Becker A, Eichelberg C, Sun M
A precision, personalized approach to the management of bladder cancer
Curr Opin Urol. 2015;25(5): 416-7; Apolo AB, Burger M
Urinary diversion: tailored solutions for individual patients
Curr Opin Urol. 2015;25(5): 436-40; Pycha A, Burger M, Palermo S
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer
Eur Urol. 2015;68(5): 837-47; Eichelberg C, Vervenne WL, De Santis M, Fischer von Weikersthal L, Goebell PJ, Lerchenmüller C, Zimmermann U, Bos MM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Flörcken A, van Arkel C, Hauswald K, Indorf M, Gottstein D, Michel MS
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]
Eur Urol. 2015;68(1): 171; Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
Eur Urol. 2015;68(5): 868-79; Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Böhle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF
Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer
Expert Rev Anticancer Ther. 2015;15(6): 649-66; Aziz A, Kempkensteffen C, May M, Lebentrau S, Burger M, Chun FK, Brookman-May S
REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis
Future Oncol. 2015;11(21): 2893-903; Bracarda S, Rottey S, Bahl A, Eichelberg C, Mellado B, Mangel L, Cattaneo A, Panneerselvam A, Grünwald V
Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder
Int J Clin Exp Pathol. 2015;8(7): 8143-58; Molitor M, Junker K, Eltze E, Toma M, Denzinger S, Siegert S, Knuechel R, Gaisa NT
Management of rectourinary fistula after urological interventions using biodesigned mesh: first experiences of an innovative technique
Int J Colorectal Dis. 2015;30(10): 1417-22; Gierth M, Denzinger S, Liebig-Hörl G, Burger M, Fürst A bründl
Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy
J Cancer Res Clin Oncol. 2015;141(10): 1819-26; Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, Salvadori U, Bründl J, Fritsche HM, Hofstädter F, Pawlik MT, Otto W, May M, Burger M, Denzinger S
Postoperative Leukocytosis After Robotic-Assisted Radical Prostatectomy Is Not Associated with Perioperative Outcome and Histopathological Findings
J Laparoendosc Adv Surg Tech A. 2015;25(10): 808-13; Ahmed A, Eckerl M, Bründl J, Peter J, Lebentrau S, Brookman-May S, Fritsche HM, Burger M, May M, Gilfrich C
Impaired vigilance is associated with erectile dysfunction in patients with sleep apnea
J Sex Med. 2015;12(2): 405-15; Popp R, Kleemann Y, Burger M, Pfeifer M, Arzt M, Budweiser S
Anatomical study of pelvic nerves in relation to seminal vesicles, prostate and urethral sphincter: immunohistochemical staining, computerized planimetry and 3-dimensional reconstruction
J Urol. 2015;193(4): 1205-12; Ganzer R, Stolzenburg JU, Neuhaus J, Weber F, Fuchshofer R, Burger M, Bründl J
Urinary tract infection
MMW Fortschr Med. 2015;157(8): 45, Brummeisl W
Frequency of TERT Promoter Mutations in Prostate Cancer
Pathobiology. 2015;82(2): 53-7, Stoehr R, Taubert H, Zinnall U, Giedl J, Gaisa NT, Burger M, Ruemmele P, Hurst CD, Knowles MA, Wullich B, Hartmann A
A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis
Pathol Res Pract. 2015;211(9): 641-645; May M, Brookman-May S, Burger M, Koch S, Otto W, Bründl J, Albrecht K, Denzinger S
Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study
Urol Int. 2015;94(1): 37-44; Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, Denzinger S, Fritsche HM, Burger M, Gierth M
Urethral condylomata acuminata
Urologe A. 2015;54(3): 378-84; Brummeisl W, Lausenmeyer E, Weber F, Bründl J, Fritsche HM, Burger M, Denzinger S
Regional for residents: GeSRU programs at regional urology meetings in 2015
Urologe A. 2015;54(4): 558-9; Bründl J, Schneidewind L, Salem J, Borgmann H
Non-muscle-invasive high-grade bladder cancer
Urologe A. 2015;54(4): 491-8;Gakis G, Stenzl A, Horn T, Gschwend JE, Otto W, Burger M
Shock wave lithotripsy in Germany: Results of a nationwide survey
Urologe A. 2015;54(9): 1277-82; Schnabel MJ, Brummeisl W, Burger M, Rassweiler JJ, Knoll T, Neisius A, Chaussy CG, Fritsche HM
Research activities of the GeSRU Academics urological infections group. Projects that pave the way for the best group performance.
Urologe A. 2015;54(6): 875-7; Schneidewind L, Boehm K, Spachmann P, Siegel F, Huck N, Kranz J, Fritsche HM
Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta
World J Urol. 2015;33(12): 1945-50; Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, Herrmann E, Keck B, Wullich B, Mayr R, Fritsche HM, Burger M, Bastian PJ, Seitz C, Brookman-May S, Xylinas E, Shariat SF, Fisch M, May M, PROMETRICS 2011 Research Group
Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life
World J Urol. 2015;33(3): 421-6; Becker A, Pradel L, Kluth L, Schmid M, Eichelberg C, Ahyai S, Trinh Q, Seiler D, Dahlem R, Hansen J, Rink M, Zacharias M, Mehnert A, Bergelt C, Fisch M, Chun FK
Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer
World J Urol. 2015;33(1): 99-104; Ganzer R, Bründl J, Koch D, Wieland WF, Burger M, Blana A
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series
World J Urol. 2015;33(3): 343-50; May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder
World J Urol. 2015;33(11): 1753-61; Novotny V, Froehner M, May M, Protzel C, Hergenröther K, Rink M, Chun FK, Fisch M, Roghmann F, Palisaar RJ, Noldus J, Gierth M, Fritsche HM, Burger M, Sikic D, Keck B, Wullich B, Nuhn P, Buchner A, Stief CG, Vallo S, Bartsch G, Haferkamp A, Bastian PJ, Hakenberg OW, Propping S, Aziz A
Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study
World J Urol. 2015;33(7): 1005-13; Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martínez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma
World J Urol. 2015;33(10): 1561-9; Quaas A, Rahvar AH, Burdelski C, Koop C, Eichelberg C, Rink M, Dahlem R, Schlomm T, Tsourlakis MC, Simon R, Minner S, Sauter G, Steurer S
Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer
World J Urol. 2015;33(12): 1959-64; Rubenwolf P, Thomas C, Denzinger S, Hartmann A, Burger M, Georgopoulos NT, Otto W
Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer
World J Urol. 2015;33(5): 725-31; Vergho D, Burger M, Schrammel M, Brookman-May S, Gierth M, Hoschke B, Lopau K, Gilfrich C, Riedmiller H, Wolff I, May M
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz@csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie@csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
